Lim et al. engineered a pH-responsive polymeric NP incorporating an anti-PD-L1 mAb (anti-PD-L1-NP) to block PD-1/PD-L1 signaling in a subcutaneous MC38 colon cancer model. Here, CD274 is linked to colonic neoplasm.